Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Sxt Pharmaceuticals (SXTC)
:SXTC
Holding SXTC?
Track your performance easily
SXTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.30 - $3.37
Previous CloseN/A
Volume317.99K
Average Volume (3M)2.01M
Market Cap
$1.43M
Enterprise ValueN/A
Total Cash (Recent Filing)$65.57K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)0.2
Beta1.79
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.20
Shares Outstanding3,476,091
10 Day Avg. Volume751,492
30 Day Avg. Volume2,008,979
Standard Deviation0.30
R-Squared0.03
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China SXT Pharmaceuticals News
PremiumCompany Announcements
China SXT Pharmaceuticals Announces New Investment Deal
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.44% Other Institutional Investors
99.56% Public Companies and
Individual Investors
SXTC FAQ
What was China Sxt Pharmaceuticals’s price range in the past 12 months?
China Sxt Pharmaceuticals lowest stock price was $0.30 and its highest was $3.37 in the past 12 months.
What is China Sxt Pharmaceuticals’s market cap?
China Sxt Pharmaceuticals’s market cap is $1.43M.
When is China Sxt Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China Sxt Pharmaceuticals’s earnings last quarter?
China Sxt Pharmaceuticals released its earnings results on Mar 28, 2019. The company reported $3.29 earnings per share for the quarter, beating the consensus estimate of N/A by $3.29.
Is China Sxt Pharmaceuticals overvalued?
According to Wall Street analysts China Sxt Pharmaceuticals’s price is currently Overvalued.
Does China Sxt Pharmaceuticals pay dividends?
China Sxt Pharmaceuticals does not currently pay dividends.
What is China Sxt Pharmaceuticals’s EPS estimate?
China Sxt Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Sxt Pharmaceuticals have?
China Sxt Pharmaceuticals has 3,476,091 shares outstanding.
What happened to China Sxt Pharmaceuticals’s price movement after its last earnings report?
China Sxt Pharmaceuticals reported an EPS of $3.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of China Sxt Pharmaceuticals?
Currently, no hedge funds are holding shares in SXTC
---
Company Description
China Sxt Pharmaceuticals
China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
---
Technical Analysis
China Pharma Holdings
―
Avenue Therapeutics
―
Aptorum Group
―
Altamira Therapeutics
―
Aethlon Medical
―
Eton Pharmaceuticals
―
---